W.S. Daniel Tan

1.8k total citations
27 papers, 1.4k citations indexed

About

W.S. Daniel Tan is a scholar working on Molecular Biology, Immunology and Complementary and alternative medicine. According to data from OpenAlex, W.S. Daniel Tan has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Complementary and alternative medicine. Recurrent topics in W.S. Daniel Tan's work include Andrographolide Research and Applications (7 papers), Asthma and respiratory diseases (7 papers) and Inflammasome and immune disorders (4 papers). W.S. Daniel Tan is often cited by papers focused on Andrographolide Research and Applications (7 papers), Asthma and respiratory diseases (7 papers) and Inflammasome and immune disorders (4 papers). W.S. Daniel Tan collaborates with scholars based in Singapore, France and United States. W.S. Daniel Tan's co-authors include W.S. Fred Wong, Wupeng Liao, Hong Yong Peh, Shuo Zhou, Dan Mei, Tze Khee Chan, Thai Tran, Han‐Ming Shen, Na Li and Bevin P. Engelward and has published in prestigious journals such as The Journal of Immunology, Free Radical Biology and Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

W.S. Daniel Tan

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.S. Daniel Tan Singapore 19 497 253 236 198 188 27 1.4k
Wupeng Liao Singapore 20 461 0.9× 223 0.9× 194 0.8× 199 1.0× 138 0.7× 39 1.2k
Hong Yong Peh Singapore 17 543 1.1× 253 1.0× 131 0.6× 231 1.2× 279 1.5× 33 1.5k
In‐Chul Lee South Korea 21 465 0.9× 168 0.7× 145 0.6× 173 0.9× 91 0.5× 81 1.3k
Qiang-min Xie China 28 787 1.6× 439 1.7× 147 0.6× 400 2.0× 417 2.2× 99 2.1k
Iraj Khodadadi Iran 26 523 1.1× 106 0.4× 87 0.4× 121 0.6× 202 1.1× 130 2.0k
Yuhang Li China 20 552 1.1× 197 0.8× 281 1.2× 181 0.9× 121 0.6× 119 1.4k
Dina S. El‐Agamy Egypt 23 470 0.9× 101 0.4× 194 0.8× 135 0.7× 100 0.5× 60 1.5k
Ghada M. Suddеk Egypt 28 546 1.1× 123 0.5× 259 1.1× 161 0.8× 167 0.9× 77 1.8k
Yue Shi China 22 733 1.5× 94 0.4× 187 0.8× 130 0.7× 176 0.9× 76 1.6k
Eugenia Mata‐Greenwood United States 22 710 1.4× 468 1.8× 74 0.3× 132 0.7× 327 1.7× 44 1.9k

Countries citing papers authored by W.S. Daniel Tan

Since Specialization
Citations

This map shows the geographic impact of W.S. Daniel Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.S. Daniel Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.S. Daniel Tan more than expected).

Fields of papers citing papers by W.S. Daniel Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.S. Daniel Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.S. Daniel Tan. The network helps show where W.S. Daniel Tan may publish in the future.

Co-authorship network of co-authors of W.S. Daniel Tan

This figure shows the co-authorship network connecting the top 25 collaborators of W.S. Daniel Tan. A scholar is included among the top collaborators of W.S. Daniel Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.S. Daniel Tan. W.S. Daniel Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tan, W.S. Daniel, et al.. (2023). Anti-fibrotic strategies and pulmonary fibrosis. Advances in pharmacology. 98. 179–224. 4 indexed citations
3.
Tan, W.S. Daniel, et al.. (2020). Polypharmacology of andrographolide: beyond one molecule one target. Natural Product Reports. 38(4). 682–692. 27 indexed citations
4.
Mei, Dan, et al.. (2020). Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD. Pharmacological Research. 161. 105223–105223. 15 indexed citations
5.
Herr, Deron R., et al.. (2020). Ultrastructural Characteristics of DHA-Induced Pyroptosis. NeuroMolecular Medicine. 22(2). 293–303. 41 indexed citations
6.
Tan, W.S. Daniel, et al.. (2020). From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action. European Journal of Medicinal Chemistry. 204. 112481–112481. 21 indexed citations
7.
Tan, W.S. Daniel, et al.. (2020). Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacological Research. 158. 104901–104901. 136 indexed citations
8.
Tavares, Luciana P., Hong Yong Peh, W.S. Daniel Tan, et al.. (2020). Granulocyte-targeted therapies for airway diseases. Pharmacological Research. 157. 104881–104881. 16 indexed citations
9.
Mei, Dan, W.S. Daniel Tan, Yvonne Tay, Amartya Mukhopadhyay, & W.S. Fred Wong. (2020). Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease. Trends in Pharmacological Sciences. 41(7). 475–486. 49 indexed citations
10.
Tan, W.S. Daniel, Han‐Ming Shen, & W.S. Fred Wong. (2019). Dysregulated autophagy in COPD: A pathogenic process to be deciphered. Pharmacological Research. 144. 1–7. 47 indexed citations
11.
Liao, Wupeng, et al.. (2018). Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury. Molecular Therapy — Nucleic Acids. 12. 370–380. 19 indexed citations
12.
Tan, W.S. Daniel, et al.. (2018). Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells. Toxicology and Applied Pharmacology. 360. 120–130. 47 indexed citations
13.
Tan, W.S. Daniel, Wupeng Liao, Shuo Zhou, & W.S. Fred Wong. (2017). Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochemical Pharmacology. 139. 71–81. 135 indexed citations
14.
Tan, W.S. Daniel, Wupeng Liao, Shuo Zhou, Dan Mei, & W.S. Fred Wong. (2017). Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases. Current Opinion in Pharmacology. 40. 9–17. 140 indexed citations
15.
Peh, Hong Yong, et al.. (2017). Vitamin E isoform γ-tocotrienol protects against emphysema in cigarette smoke-induced COPD. Free Radical Biology and Medicine. 110. 332–344. 38 indexed citations
16.
Chan, Tze Khee, Hong Yong Peh, Wenzhi Tan, et al.. (2016). House dust mite–induced asthma causes oxidative damage and DNA double-strand breaks in the lungs. Journal of Allergy and Clinical Immunology. 138(1). 84–96.e1. 111 indexed citations
17.
Liao, Wupeng, W.S. Daniel Tan, & W.S. Fred Wong. (2016). Andrographolide Restores Steroid Sensitivity To Block Lipopolysaccharide/IFN-γ–Induced IL-27 and Airway Hyperresponsiveness in Mice. The Journal of Immunology. 196(11). 4706–4712. 24 indexed citations
18.
Peh, Hong Yong, W.S. Daniel Tan, Wupeng Liao, & W.S. Fred Wong. (2015). Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol. Pharmacology & Therapeutics. 162. 152–169. 266 indexed citations
19.
Ng, David S.W., et al.. (2014). Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine. 21(12). 1638–1644. 42 indexed citations
20.
Tan, W.S. Daniel, et al.. (2012). Detectability of secretagogin in human erythrocytes. Neuroscience Letters. 526(1). 59–62. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wupeng Liao Breakdown of academic impact, for papers by Hong Yong Peh Breakdown of academic impact, for papers by In‐Chul Lee Breakdown of academic impact, for papers by Qiang-min Xie Breakdown of academic impact, for papers by Iraj Khodadadi Breakdown of academic impact, for papers by Yuhang Li Breakdown of academic impact, for papers by Dina S. El‐Agamy Breakdown of academic impact, for papers by Ghada M. Suddеk Breakdown of academic impact, for papers by Yue Shi Breakdown of academic impact, for papers by Eugenia Mata‐Greenwood
Rankless by CCL
2026